HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antitumor effects of anti-CD40/CpG immunotherapy combined with gemcitabine or 5-fluorouracil chemotherapy in the B16 melanoma model.

Abstract
Our previous studies demonstrated that anti-CD40 mAb (anti-CD40) can synergize with CpG oligodeoxynucleotides (CpG) to mediate antitumor effects by activating myeloid cells, such as macrophages in tumor-bearing mice. Separate teams have shown that chemotherapy with gemcitabine (GEM) or 5-fluorouracil (5-FU) can reduce tumor-induced myeloid-derived suppressor cells (MDSC) in mice. In this study we asked if the same chemotherapy regimens with GEM or 5-FU will enhance the antitumor effect of anti-CD40 and CpG. Using the model of B16 melanoma growing intraperitoneally in syngeneic C57BL/6 mice, we show that these GEM or 5-FU treatment regimens reduced MDSC in the peritoneal cavity of tumor-bearing mice. Treatment of mice with GEM or 5-FU did not significantly affect the antitumor function of macrophages as assessed in vitro. In vivo, treatment with these GEM or 5-FU regimens followed by anti-CD40/CpG resulted in antitumor effects similar to those of anti-CD40/CpG in the absence of GEM or 5-FU. Likewise, reduction of MDSC by in vivo anti-Gr-1 mAb treatment did not significantly affect anti-CD40/CpG antitumor responses. Together, the results show that the GEM or 5-FU chemotherapy regimens did not substantially affect the antitumor effects induced by anti-CD40/CpG immunotherapy.
AuthorsXiaoyi Qu, Mildred A R Felder, Zulmarie Perez Horta, Paul M Sondel, Alexander L Rakhmilevich
JournalInternational immunopharmacology (Int Immunopharmacol) Vol. 17 Issue 4 Pg. 1141-7 (Dec 2013) ISSN: 1878-1705 [Electronic] Netherlands
PMID24201083 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2013.
Chemical References
  • Adjuvants, Immunologic
  • Antimetabolites, Antineoplastic
  • CD40 Antigens
  • CPG-oligonucleotide
  • Cancer Vaccines
  • Nitrites
  • Oligodeoxyribonucleotides
  • Deoxycytidine
  • Fluorouracil
  • Gemcitabine
Topics
  • Adjuvants, Immunologic (administration & dosage)
  • Animals
  • Antimetabolites, Antineoplastic (administration & dosage)
  • Antineoplastic Combined Chemotherapy Protocols (administration & dosage)
  • CD40 Antigens (immunology)
  • Cancer Vaccines
  • Cell Line, Tumor
  • Deoxycytidine (administration & dosage, analogs & derivatives)
  • Female
  • Fluorouracil (administration & dosage)
  • Immunotherapy
  • Macrophages (drug effects, metabolism)
  • Melanoma, Experimental (metabolism, pathology, therapy)
  • Mice
  • Mice, Inbred C57BL
  • Nitrites (metabolism)
  • Oligodeoxyribonucleotides (administration & dosage, immunology)
  • Skin Neoplasms (metabolism, pathology, therapy)
  • Tumor Burden (drug effects)
  • Gemcitabine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: